B.A.

Wonderful. Waiting for the next installment

Revisado: 05-15-22

Excellent. Very well read. Super engaging. Eagerly awaiting the next installment and to hear the story of JFK. I was inspired to watch his two documentaries on Ukraine. His new movie-lengthy documentary on the JFK killing is next on my viewing list. Thank god for Oliver Stone.

Has calificado esta reseña.

Reportaste esta reseña

Great book. Masterly and substantive polemic. polemic. Chapter 5 on solutions could and should be a game changer.

Revisado: 12-16-21

See my subject line. Excellent book. Very well read by the author. Nothing else to add. Don’t miss it.

Has calificado esta reseña.

Reportaste esta reseña

Unintelligible.

Revisado: 10-11-20

If you can understand this book, you don't need to read it.

Who is the editor of this series? The book is marketed as if it will explain a subject to the outsider or neophyte, yet this one is more like a sophisticated essay that explains very little yet requires a deep understanding to grasp the author's points, which are almost with out exception, subtle ones. I understood maybe 10 percent of the book. I suspect that if I listened again, I would then understand 20 per cent. I gave the book two stars rather than one because I suspect that for a scholar of critical theory, the book could provide some deep and important insights.

But overall, what was that editor--or that author--thinking in including this book for this series?

Has calificado esta reseña.

Reportaste esta reseña

esto le resultó útil a 1 persona

Potentially Biased and But Still Useful

Revisado: 02-21-20

This brief audio contains some good information for businesses, but it is also is biased and may be a scam. The main interview is with the head of emergency business continuity planning at Roche, the pharmaceutical company. Is it a coincidence that Roche makes Tamiflu, an antiviral medication that is being sold to stockpile for a flu pandemic? In fact, it is unclear how effective Tamiflu would actually be, and Roche has been sued over this question. Though the interview covers some important issues in general, the name "Tamiflu" also happens to appear (I would call this a "product placement") in the interview two or three times. Though it is handled subtly, such subtlety -- which mixes potentially useful information with advertising -- is the essence of selling pharmaceuticals. For many, one of the take home messages may be: Think Tamiflu!

Whether or not Tamiflu is worth purchasing is a different question, and one that should be made independently of Roche's advertising or infomercials or input. I found myself wondering, in fact, if the producer of this audio (the AMA -- the American Manufacturing Association, not the American Medical Association) had accepted money form Roche for the creation of this audio. If so, then the entire thing is unethical; and if the AMA didn't accept money, they should have realized that it was inappropriate, unethical, and potentially biased for someone from Roche to be the main source of information.

That said, if one goes in with one's eyes wide open, and entirely separates out the question of Tamiflu from continuity planning for a pandemic, the audio can be useful. Lacking something else, it's worth listening to, but the program should be replaced with a serious and unbiased and fully ethical attempt by the AMA to create meaningful audio on this topic,

Has calificado esta reseña.

Reportaste esta reseña

Well-done and thought-provoking polemic

Revisado: 08-01-19

A well-done and thought-provoking polemic. Brief but not too brief. Would like to listen to author’s new book on black power on audible and wondering if / when it will be available in audible format.

Has calificado esta reseña.

Reportaste esta reseña